Cerebral Artery Syndrome Treatment Market - Regional Analysis
North American Market Insights
North America industry is set to account for largest revenue share of 35% by 2035, The growth can be attributed to the growing awareness among individuals regarding minimally invasive stroke treatment in the region. Also, the growing prevalence of atrial fibrillation is also driving the market growth in the region. As per a report, in the US, there are annually more than 454,000 hospital admissions with AFib as the major diagnosis. Each year, the illness is a contributing factor in over 158,000 deaths.
APAC Market Insights
Asia Pacific region in cerebral artery syndrome treatment market is anticipated to hold the second-largest share of 26% during the projected period. The market is growing in the region due to the increasing initiatives taken by the government in the region to spread awareness about the condition. Also, growing investment for the betterment of healthcare infrastructure is propelling the market growth. As per a report, the region invested around USD 10.8 billion from 2008 to 2021 in the healthcare industry. Furthermore, growing R&D activities for the advent of new and advanced treatments are also accelerating the market growth of cerebral artery syndrome treatment in the region.
